AUTOIMMUNE

April 4, 2018

Observational Study Notes Increased IBD Risk with Common Diabetes Drug

April 4, 2018

Treating Elderly for Subclinical Hypothyroidism Can Boost Mortality Rates

March 22, 2018

Evaluating Shingles Vaccine Effectiveness in High-Risk Autoimmune Patients

February 28, 2018

Rheumatology Group’s White Paper Urges Use of Biosimilar Products When Appropriate

November 22, 2017

DMARDS Don’t Appear to Raise Risk of Second Malignancy in RA Patients Who Had Cancer

November 15, 2017

Determining Which RA Patients Are Likely to Successfully Taper Off Biologics

November 1, 2017

Awareness of Transition to Biosimilar Appears to Influence Discontinuation Rate

July 19, 2017

No Benefits for Levothyroxine in Older Subclinical Hypothyroidism Patients

June 7, 2017

Triple Therapy More Cost-Effective Than Biologics for Second-Line RA Treatment

September 28, 2016

What’s Best Next Treatment for RA Patients on Anti-TNF Biologic Agents

August 18, 2016

Humira Biosimilar Backed by FDA Panel

June 16, 2016

Medication Safety Concerns Surrounding Immunomodulators

June 16, 2016

Trends in Selected Autoimmune Diseases

April 2018

April 2018

In This Issue Digital Magazine Archives Subscription

Copyright © 2000 - 2018 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.